全文获取类型
收费全文 | 5303篇 |
免费 | 484篇 |
国内免费 | 2篇 |
专业分类
5789篇 |
出版年
2023年 | 30篇 |
2022年 | 86篇 |
2021年 | 174篇 |
2020年 | 82篇 |
2019年 | 96篇 |
2018年 | 140篇 |
2017年 | 109篇 |
2016年 | 178篇 |
2015年 | 270篇 |
2014年 | 329篇 |
2013年 | 378篇 |
2012年 | 462篇 |
2011年 | 430篇 |
2010年 | 290篇 |
2009年 | 229篇 |
2008年 | 302篇 |
2007年 | 298篇 |
2006年 | 266篇 |
2005年 | 207篇 |
2004年 | 228篇 |
2003年 | 217篇 |
2002年 | 193篇 |
2001年 | 57篇 |
2000年 | 47篇 |
1999年 | 64篇 |
1998年 | 48篇 |
1997年 | 42篇 |
1996年 | 31篇 |
1995年 | 31篇 |
1994年 | 31篇 |
1993年 | 38篇 |
1992年 | 32篇 |
1991年 | 35篇 |
1990年 | 36篇 |
1989年 | 32篇 |
1988年 | 19篇 |
1987年 | 19篇 |
1986年 | 18篇 |
1985年 | 20篇 |
1984年 | 18篇 |
1983年 | 17篇 |
1982年 | 16篇 |
1981年 | 13篇 |
1980年 | 9篇 |
1979年 | 7篇 |
1978年 | 14篇 |
1977年 | 11篇 |
1974年 | 15篇 |
1970年 | 8篇 |
1968年 | 6篇 |
排序方式: 共有5789条查询结果,搜索用时 0 毫秒
81.
Galanter JM Fernandez-Lopez JC Gignoux CR Barnholtz-Sloan J Fernandez-Rozadilla C Via M Hidalgo-Miranda A Contreras AV Figueroa LU Raska P Jimenez-Sanchez G Zolezzi IS Torres M Ponte CR Ruiz Y Salas A Nguyen E Eng C Borjas L Zabala W Barreto G González FR Ibarra A Taboada P Porras L Moreno F Bigham A Gutierrez G Brutsaert T León-Velarde F Moore LG Vargas E Cruz M Escobedo J Rodriguez-Santana J Rodriguez-Cintrón W Chapela R Ford JG Bustamante C Seminara D Shriver M Ziv E Burchard EG Haile R 《PLoS genetics》2012,8(3):e1002554
Most individuals throughout the Americas are admixed descendants of Native American, European, and African ancestors. Complex historical factors have resulted in varying proportions of ancestral contributions between individuals within and among ethnic groups. We developed a panel of 446 ancestry informative markers (AIMs) optimized to estimate ancestral proportions in individuals and populations throughout Latin America. We used genome-wide data from 953 individuals from diverse African, European, and Native American populations to select AIMs optimized for each of the three main continental populations that form the basis of modern Latin American populations. We selected markers on the basis of locus-specific branch length to be informative, well distributed throughout the genome, capable of being genotyped on widely available commercial platforms, and applicable throughout the Americas by minimizing within-continent heterogeneity. We then validated the panel in samples from four admixed populations by comparing ancestry estimates based on the AIMs panel to estimates based on genome-wide association study (GWAS) data. The panel provided balanced discriminatory power among the three ancestral populations and accurate estimates of individual ancestry proportions (R2 > 0.9 for ancestral components with significant between-subject variance). Finally, we genotyped samples from 18 populations from Latin America using the AIMs panel and estimated variability in ancestry within and between these populations. This panel and its reference genotype information will be useful resources to explore population history of admixture in Latin America and to correct for the potential effects of population stratification in admixed samples in the region. 相似文献
82.
83.
84.
Jocelyn Chan Joyce Chan Lily Shao Scott S. Stawicki Victoria C. Pham Rob W. Akita Marc Hafner Lisa Crocker Kebing Yu James T. Koerber Gabriele Schaefer Laetitia Comps-Agrar 《The Journal of biological chemistry》2023,299(1)
Fibroblast growth factor receptor 1 (FGFR1) is a receptor tyrosine kinase that plays a major role in developmental processes and metabolism. The dysregulation of FGFR1 through genetic aberrations leads to skeletal and metabolic diseases as well as cancer. For this reason, FGFR1 is a promising therapeutic target, yet a very challenging one due to potential on-target toxicity. More puzzling is that both agonistic and antagonistic FGFR1 antibodies are reported to exhibit similar toxicity profiles in vivo, namely weight loss. In this study, we aimed to assess and compare the mechanism of action of these molecules to better understand this apparent contradiction. By systematically comparing the binding of these antibodies and the activation or the inhibition of the major FGFR1 signaling events, we demonstrated that the molecules displayed similar properties and can behave either as an agonist or antagonist depending on the presence or the absence of the endogenous ligand. We further demonstrated that these findings translated in xenografts mice models. In addition, using time-resolved FRET and mass spectrometry analysis, we showed a functionally distinct FGFR1 active conformation in the presence of an antibody that preferentially activates the FGFR substrate 2 (FRS2)-dependent signaling pathway, demonstrating that modulating the geometry of a FGFR1 dimer can effectively change the signaling outputs and ultimately the activity of the molecule in preclinical studies. Altogether, our results highlighted how bivalent antibodies can exhibit both agonistic and antagonistic activities and have implications for targeting other receptor tyrosine kinases with antibodies. 相似文献
85.
Mao Y Shang Y Pham VC Ernst JA Lill JR Scales SJ Zha J 《The Journal of biological chemistry》2011,286(48):41852-41861
Ubiquitination has been implicated in negatively regulating insulin-like growth factor I receptor (IGF-IR) activity. Because of the relative stability of IGF-IR in the presence of ligand stimulation, IGF-IR ubiquitination sites have yet to be mapped and characterized, thus preventing a direct demonstration of how the receptor ubiquitination contributes to downstream molecular cascades. We took advantage of an anti-IGF-IR antibody (h10H5) that induces more efficient receptor down-regulation to show that IGF-IR is promptly and robustly ubiquitinated. The ubiquitination sites were mapped to the two lysine residues in the IGF-IR activation loop (Lys-1138 and Lys-1141) and consisted of polyubiquitin chains formed through both Lys-48 and Lys-29 linkages. Mutation of these ubiquitinated lysine residues resulted in decreased h10H5-induced IGF-IR internalization and down-regulation as well as a reduced cellular response to h10H5 treatment. We have therefore demonstrated that IGF-IR ubiquitination contributes critically to the down-regulating and antiproliferative activity of h10H5. This finding is physiologically relevant because insulin-like growth factor I appears to mediate ubiquitination of the same major sites as h10H5 (albeit to a lesser extent), and ubiquitination is facilitated by pre-existing phosphorylation of the receptor in both cases. Furthermore, identification of a breast cancer cell line with a defect in IGF-IR ubiquitination suggests that this could be an important tumor resistance mechanism to evade down-regulation-mediated negative regulation of IGF-IR activity in cancer. 相似文献
86.
Pyridoxal 5′-phosphate is the active form of vitamin B6 and its deficiency is directly related with several human disorders, which make human pyridoxal kinase (hPLK) an important pharmacologic target. In spite of this, a carefully kinetic characterization of hPLK including the main species that regulates the enzymatic activity is at date missing. Here we analyse the catalytic and regulatory mechanisms of hPLK as a function of a precise determination of the species involved in metal–nucleotide equilibriums and describe new regulatory mechanisms for this enzyme. hPLK activity is supported by several metals, being Zn2+ the most effective, although the magnitude of the effect observed is highly dependent on the relative concentrations of metal and nucleotide used. The true substrate for the reaction catalyzed by hPLK is the metal nucleotide complex, while ATP4? and HATP3? did not affect the activity. The enzyme presents substrate inhibition by both pyridoxal (PL) and ZnATP2?, although the latter behaves as a weakly inhibitor. Our study also established, for the first time, a dual role for free Zn2+; as an activator at low concentrations (19 μM optimal concentration) and as a potent inhibitor with a IC50 of 37 μM. These results highlighted the importance of an accurate estimation of the actual concentration of the species involved in metal–nucleotide equilibriums in order to obtain reliable values for the kinetic parameters, and for determine the true regulators of the PLK activity. They also help to explain the dissimilar kinetic parameters reported in the literature for this enzyme. 相似文献
87.
88.
89.
NF Gallardo-Romero CP Drew SL Weiss MG Metcalfe YJ Nakazawa SK Smith GL Emerson CL Hutson JS Salzer JH Bartlett VA Olson CJ Clemmons WB Davidson SR Zaki KL Karem IK Damon DS Carroll 《PloS one》2012,7(8):e43881
Volepox virus (VPXV) was first isolated in 1985 from a hind foot scab of an otherwise healthy California vole (Microtus californicus). Subsequent surveys in San Mateo County, CA, revealed serological evidence suggesting that VPXV is endemic to this area, and a second viral isolate from a Pinyon mouse (Peromyscus truei) was collected in 1988. Since then, few studies have been conducted regarding the ecology, pathology, and pathogenicity of VPXV, and its prevalence and role as a potential zoonotic agent remain unknown. To increase our understanding of VPXV disease progression, we challenged 24 California mice (Peromyscus californicus) intranasally with 1.6×10(3) PFU of purified VPXV. By day five post infection (pi) we observed decreased activity level, conjunctivitis, ruffled hair, skin lesions, facial edema, and crusty noses. A mortality rate of 54% was noted by day eight pi. In addition, internal organ necrosis and hemorrhages were observed during necropsy of deceased or euthanized animals. Viral loads in tissues (brain, gonad, kidney, liver, lung, spleen, submandibular lymph node, and adrenal gland), bodily secretions (saliva, and tears), and excretions (urine, and/or feces) were evaluated and compared using real time-PCR and tissue culture. Viral loads measured as high as 2×10(9) PFU/mL in some organs. Our results suggest that VPXV can cause extreme morbidity and mortality within rodent populations sympatric with the known VPXV reservoirs. 相似文献
90.